Search
for
Sort by
Research 91–120 of 1000+
- Effects of local and systemic medications on eye health: Adverse reactions
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Flutamide-Loaded Zein Nanocapsule Hydrogel, a Promising Dermal Delivery System for Pilosebaceous Unit Disorders
- Tacrolimus in Dermatology
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Telogen Effluvium
- Ancient-modern concordance in Ayurvedic plants: some examples.
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Human hair follicle organ culture: theory, application and perspectives
- Recent Trends and Future Prospects of Phytosomes: A Concise Review
- Recent advances in electrospun nanofibers for wound healing
- Stability of opiates in hair fibers after exposure to cosmetic treatment
- Systemic causes of hair loss
- Hair Growth Stimulation Effect of Centipeda minima Extract: Identification of Active Compounds and Anagen-Activating Signaling Pathways
- Lipid nanocarriers as innovative strategies for hair regrowth
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Quantitative Models for the Study of Hair Growth <i>in Vivo</i><sup>a</sup>
- Microneedling in Dermatology: A Review
- Alopecias
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Laboratory Testing in Telogen Effluvium
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- A Gender Hypothesis of sex disparities in adverse drug events
- Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Referee report. For: Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review [version 1; peer review: 2 approved with reservations]
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications